Mutation in Bmpr1b Leads to Optic Disc Coloboma and Ventral Retinal Gliosis in Mice.
Journal
Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701
Informations de publication
Date de publication:
07 02 2020
07 02 2020
Historique:
entrez:
28
2
2020
pubmed:
28
2
2020
medline:
16
4
2020
Statut:
ppublish
Résumé
The clinical phenotype of retinal gliosis occurs in different forms; here, we characterize one novel genetic feature, (i.e., signaling via BMP-receptor 1b). Mouse mutants were generated within a recessive ENU mutagenesis screen; the underlying mutation was identified by linkage analysis and Sanger sequencing. The eye phenotype was characterized by fundoscopy, optical coherence tomography, optokinetic drum, electroretinography, and visual evoked potentials, by histology, immunohistology, and electron-microscopy. The mutation affects intron 10 of the Bmpr1b gene, which is causative for skipping of exon 10. The expression levels of pSMAD1/5/8 were reduced in the mutant retina. The loss of BMPR1B-mediated signaling leads to optic nerve coloboma, gliosis in the optic nerve head and ventral retina, defective optic nerve axons, and irregular retinal vessels. The ventral retinal gliosis is proliferative and hypertrophic, which is concomitant with neuronal delamination and the reduction of retinal ganglion cells (RGCs); it is dominated by activated astrocytes overexpressing PAX2 and SOX2 but not PAX6, indicating that they may retain properties of gliogenic precursor cells. The expression pattern of PAX2 in the optic nerve head and ventral retina is altered during embryonic development. These events finally result in reduced electrical transmission of the retina and optic nerve and significantly reduced visual acuity. Our study demonstrates that BMPR1B is necessary for the development of the optic nerve and ventral retina. This study could also indicate a new mechanism in the formation of retinal gliosis; it opens new routes for its treatment eventually preventing scar formation in the retina.
Identifiants
pubmed: 32106289
pii: 2762334
doi: 10.1167/iovs.61.2.44
pmc: PMC7329948
doi:
Substances chimiques
BMPR1B protein, human
EC 2.7.11.30
Bone Morphogenetic Protein Receptors, Type I
EC 2.7.11.30
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
44Références
Dev Biol. 2009 Aug 15;332(2):429-43
pubmed: 19505455
Vet Ophthalmol. 2005 Sep-Oct;8(5):319-23
pubmed: 16178842
Development. 2000 Feb;127(3):621-30
pubmed: 10631182
Genes Dev. 1995 Nov 15;9(22):2808-20
pubmed: 7590255
Am J Physiol Heart Circ Physiol. 2005 Dec;289(6):H2334-41
pubmed: 15964923
Curr Neurol Neurosci Rep. 2013 Jul;13(7):363
pubmed: 23703240
Hum Mol Genet. 2014 Nov 1;23(21):5597-614
pubmed: 24895407
Dev Biol. 2007 Mar 15;303(2):800-13
pubmed: 17173889
PLoS Genet. 2010 Mar 05;6(3):e1000870
pubmed: 20221250
J Biol Chem. 2004 May 7;279(19):19800-7
pubmed: 15001570
Development. 2002 Aug;129(15):3727-37
pubmed: 12117821
ASN Neuro. 2011 Jun 16;3(3):e00061
pubmed: 21599637
Neurosci Lett. 2014 Apr 17;565:30-8
pubmed: 24406153
Dev Biol. 1998 May 15;197(2):155-69
pubmed: 9630743
Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3764-73
pubmed: 20130285
Genes Dev. 1998 Dec 1;12(23):3764-75
pubmed: 9851982
Doc Ophthalmol. 2013 Jun;126(3):221-32
pubmed: 23519764
Dev Biol. 2009 Sep 1;333(1):37-47
pubmed: 19545559
Hum Mol Genet. 2012 May 15;21(10):2357-69
pubmed: 22357656
Mamm Genome. 2011 Oct;22(9-10):495-505
pubmed: 21553221
Dev Biol. 2003 Apr 1;256(1):34-48
pubmed: 12654290
Exp Eye Res. 2013 Jun;111:9-16
pubmed: 23523800
Neural Dev. 2009 Aug 17;4:32
pubmed: 19686589
Dev Biol. 2005 Mar 15;279(2):308-21
pubmed: 15733660
Nat Methods. 2005 Jun;2(6):403-4
pubmed: 15908916
PLoS Genet. 2009 Jun;5(6):e1000511
pubmed: 19521500
J Neuroinflammation. 2017 Apr 5;14(1):76
pubmed: 28381236
Cancer Cell. 2008 Jan;13(1):69-80
pubmed: 18167341
Methods Mol Biol. 2009;530:463-509
pubmed: 19266331
Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4611-6
pubmed: 15557474
Mol Cell Neurosci. 2011 Jun;47(2):119-30
pubmed: 21447391
Hum Mol Genet. 2011 Sep 15;20(18):3620-31
pubmed: 21680557
J Med Genet. 2004 Dec;41(12):881-91
pubmed: 15591273
J AAPOS. 2008 Apr;12(2):117-21
pubmed: 18083586
Mamm Genome. 2000 Jul;11(7):528-30
pubmed: 10886017
Eye (Lond). 2004 Nov;18(11):1038-48
pubmed: 15534588
Hum Genet. 2011 Oct;130(4):495-504
pubmed: 21340693
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W496-500
pubmed: 15980520
J Comp Neurol. 2000 Aug 14;424(1):1-23
pubmed: 10888735
Exp Eye Res. 2007 Feb;84(2):349-60
pubmed: 17141759
J Neurosci. 2001 Feb 15;21(4):1292-301
pubmed: 11160400
Am J Hum Genet. 2008 Feb;82(2):304-19
pubmed: 18252212
Nat Genet. 2000 Aug;25(4):444-7
pubmed: 10932192
Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13870-5
pubmed: 8943028
Science. 2001 Jul 6;293(5527):111-5
pubmed: 11441185
Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3581-6
pubmed: 18299565
Development. 2006 Aug;133(16):3179-90
pubmed: 16854970
Mamm Genome. 2013 Jun;24(5-6):198-205
pubmed: 23681115
Curr Opin Genet Dev. 2002 Aug;12(4):430-4
pubmed: 12100888
Development. 2005 Mar;132(5):913-23
pubmed: 15673568
Doc Ophthalmol. 2009 Dec;119(3):181-97
pubmed: 19760280
Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3531-3542
pubmed: 30025074
Case Rep Ophthalmol. 2010 Nov 29;1(2):94-98
pubmed: 21151632
J Neurosci. 2010 Feb 3;30(5):1839-55
pubmed: 20130193
Circ J. 2012;76(6):1501-8
pubmed: 22374147
Cell Stem Cell. 2013 Jan 3;12(1):15-30
pubmed: 23290134
J Neurosci. 2004 Sep 15;24(37):8124-34
pubmed: 15371513
J Comp Neurol. 1990 Nov 15;301(3):433-42
pubmed: 2262600
Mutat Res. 1985 Jun-Jul;150(1-2):393-401
pubmed: 4000165
Mol Vis. 2014 Jul 31;20:1085-108
pubmed: 25253985
Dev Biol. 1999 Mar 1;207(1):176-88
pubmed: 10049573
Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1424-31
pubmed: 19834041
Mol Cell Neurosci. 2007 May;35(1):171-82
pubmed: 17391983
Indian J Ophthalmol. 2013 Dec;61(12):743-8
pubmed: 24413826
Int J Dev Biol. 2007;51(2):161-5
pubmed: 17294367
Genes Dev. 1995 Nov 15;9(22):2795-807
pubmed: 7590254